Status:
COMPLETED
Intraperitoneal Atomization of Levobupivacaine During Gynaecological Laparoscopic Procedures ; Impact on Pain, Opioid Use and Length of Recovery Room Stay (IPLA).
Lead Sponsor:
University Hospital, Ghent
Conditions:
Pain, Postoperative
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
In this study, we will compare 3 treatments. The first group of patients will receive the standard treatment (paracetamol, diclofenac and an opioid if necessary) with infiltration of the portal sites ...
Eligibility Criteria
Inclusion
- Patients who are planned for gynaecological laparoscopic interventions on an ambulatory basis.
Exclusion
- Less than 18 year old.
- Weight less than 50 kg and more than 80 kg.
- Pregnant.
- Prisoners;
- Allergic to topical anesthetics (Amides specifically).
- Allergic to Opioids as a class.
- Currently or within the last 30 days been prescribed an opiate medication.
- Chronic pain syndrome.
Key Trial Info
Start Date :
June 26 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 3 2018
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01886352
Start Date
June 26 2013
End Date
December 3 2018
Last Update
December 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University Hospital
Ghent, Belgium, 9000